The advertisement promotes Nucala (mepolizumab) as a treatment option for individuals with chronic obstructive pulmonary disease (COPD), suggesting it may address different aspects of the condition.
Creative Information
| CID: | b3971a3d-ecaf-4009-ad33-b3137103aa38 |
| CRID: | 89_219801 |
| Domain: | nucala.com |
| Seat: | DInt |
| Size: | 300x250 |
| Bid: | $2.61 |
| Timestamp: | 11/18/2025, 9:53:52 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/19/2025, 1:16:13 AM | 6.26s | |
| adomain_analysis | success | 11/19/2025, 2:55:49 AM | 4.28s | |
| adomain_capture | success | 11/19/2025, 2:54:40 AM | 0.14s | |
| ad_render | success | 11/19/2025, 1:16:07 AM | 27.94s | |
| brand_mapping | success | 11/18/2025, 9:53:52 PM | 0.10s | |
Analysis Results
| Size: | 300x250 | ||||||||||||||||||||||
| Data Transferred: | 1634.48 KB | ||||||||||||||||||||||
| Render Time: | 9.22 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | Domain:www.nucala.com Brand: | ||||||||||||||||||||||
| Total Ad Size: | 1655.59 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives


